Federal health regulators are warning consumers in Florida and Georgia to check their medicine cabinets after counterfeit versions of over‑the‑counter eye drops were discovered in multiple retail locations serving primarily Spanish‑speaking customers.
The U.S. Food and Drug Administration (FDA) said it has identified fake products that appear to copy legitimate brands of lubricating and redness‑relief eye drops, but are not manufactured or distributed by the approved companies. The agency disclosed the findings in a public safety communication, urging people to stop using any suspicious bottles and to report them.
What Regulators Have Found
According to the FDA, investigators recently found counterfeit versions of certain over‑the‑counter eye drops being sold in Florida and Georgia. The products were discovered in brick‑and‑mortar stores that primarily serve Spanish‑speaking communities.
The agency described the items as counterfeit because they:
- Mimic the appearance and branding of approved eye drop products
- Are not made or distributed by the legitimate manufacturers
- Were not introduced into the market through approved supply chains
The FDA did not publicly name the individual stores where the items were found, but said the affected locations were in multiple areas across the two states. The agency’s notice emphasized that the products were found on store shelves, not through online marketplaces, and that the packaging was designed to look like familiar brands.
Why Counterfeit Eye Drops Raise Safety Concerns
In its communication, the FDA warned that counterfeit eye drops may not meet basic standards for sterility, ingredient quality, or labeling accuracy. Eye drops are considered sterile products because they are applied directly to the eye, which is particularly vulnerable to infection.
The agency noted that counterfeit products:
- May contain harmful contaminants
- May lack the active ingredients needed for relief
- May include unlisted or incorrect ingredients
- May be manufactured in facilities that do not follow required quality controls
Because the fake products are designed to resemble legitimate brands, consumers may not be able to tell the difference by sight alone. The FDA urged people to pay close attention to details on labels, including spelling, lot numbers, expiration dates, and manufacturer information, and to compare them with known, trusted products when possible.
The FDA’s alert did not report confirmed injuries or specific adverse events linked to these particular counterfeit eye drops. However, the agency framed the discovery as a potential risk to eye health and overall safety, given the unknown origin and contents of the products.
Impact on Spanish‑Speaking Communities
The FDA highlighted that the counterfeit eye drops were found in stores serving primarily Spanish‑speaking customers in Florida and Georgia. That detail suggests, in the agency’s view, that people who rely on neighborhood retailers and Spanish‑language packaging may be at particular risk of encountering the fake products.
The agency’s notice underscored the importance of:
- Checking that labels include the correct manufacturer name and contact information
- Looking for tamper‑evident seals and intact packaging
- Being cautious with products that appear significantly cheaper than usual or that differ slightly from familiar packaging
The FDA’s communication did not specify whether the counterfeit items were marketed primarily in Spanish, English, or both. It did, however, stress that the affected stores cater largely to Spanish‑speaking shoppers, which shaped the focus of the warning.
How the FDA Is Responding
The FDA said it has begun working to remove the counterfeit eye drops from the marketplace in Florida and Georgia. That effort includes:
- Coordinating with state and local officials to locate and seize remaining counterfeit stock
- Notifying retailers where counterfeit products have been identified
- Advising stores to review their supply chains and pull any suspicious inventory
The agency also asked consumers and health professionals to report any suspected counterfeit eye products or adverse reactions through its MedWatch reporting system. Those reports, the FDA said, can help investigators trace the origin of the counterfeit products and identify additional locations where they may be sold.
The FDA’s notice did not provide details on how the counterfeit items first entered the retail supply chain, nor did it identify any distributors or manufacturers under investigation in connection with this incident. The agency indicated that its inquiry is ongoing.
What Consumers in Affected Areas Should Do
Based on the FDA’s public communication, consumers in Florida and Georgia who have recently purchased over‑the‑counter eye drops—especially from neighborhood or specialty stores serving Spanish‑speaking communities—are being urged to:
- Check the packaging and labels for unusual spelling, formatting errors, missing information, or differences from previous purchases of the same brand.
- Verify manufacturer information on the label against the official information on the manufacturer’s website or on trusted pharmacy shelves.
- Stop using any product that appears suspicious or that does not match known, legitimate packaging.
- Report concerns or adverse reactions related to eye drops to the FDA’s MedWatch system, as requested in the agency’s notice.
The FDA also advised that consumers who experience eye pain, changes in vision, persistent redness, or signs of infection after using any eye drops should seek medical care promptly.
Why This Matters
The discovery of counterfeit eye drops in multiple retail locations in Florida and Georgia highlights the vulnerability of everyday health products to falsification, particularly in communities that rely on smaller, local stores. While the FDA has not publicly linked these specific counterfeit items to documented injuries, the agency’s warning underscores that unregulated products applied directly to the eye can pose serious risks.
Regulators say they are continuing to investigate how the counterfeit eye drops reached store shelves and are working with local partners to remove them. For now, the FDA’s message to consumers in the affected states is straightforward: examine eye drop packaging carefully, be cautious with unfamiliar or suspicious products, and report anything that appears counterfeit so investigators can track and contain the problem.
